Roll forming kayan aiki maroki

Fiye da Shekaru 30+ Ƙwarewar Ƙirƙirar Masana'antu

Gargadi game da haxarin cakuɗa masu ƙarfafawa da alluran rigakafi

Kwararru sun nuna damuwa cewa masu samar da alluran rigakafi na iya haɗa kwalabe na ƙarfafa Omicron tare da vials da ake amfani da su don maganin alurar riga kafi.
Wadancan damuwar sun fito ne a makon da ya gabata a taron jama'a na masu ba da shawara na CDC kuma kwamitin kwararrun kiwon lafiya a jihohi hudu, ciki har da California, ya bayyana hakan a ranar Asabar, a cewar Kungiyar Tawagar Tsaron Kimiyya ta Yammacin Amurka.
A cikin wata sanarwa da kungiyar ta fitar ta ce "Idan aka yi la'akari da tsarin kungiyoyin shekaru daban-daban sun yi kama da juna, rundunar ta damu matuka cewa kurakurai na iya faruwa a cikin isar da alluran rigakafin COVID-19 daban-daban," in ji kungiyar. "Ya kamata a rarraba COVID-19 mai tsabta ga jama'a." . duk masu bada alluran rigakafi.-19 Jagororin rigakafin.
Sabuwar rigakafin ana kiranta bivalent. An tsara su don kare ba kawai daga nau'in coronavirus na asali ba, har ma da BA.5 da wani nau'in Omicron mai suna BA.4. Sabbin masu haɓakawa suna da lasisi ga mutane sama da shekaru 12 kawai.
Shots na al'ada alluran rigakafin monovalent ne waɗanda aka tsara don kariya kawai daga nau'in cutar coronavirus na asali.
Rikici mai yuwuwa yana da alaƙa da launin hular kwalbar. Wasu sabbin alluran ƙarfafawa suna da iyakoki masu launi iri ɗaya da tsoffin allura.
Misali, alluran bivalent na al'ada da sabbin Pfizer ga mutanen da ke da shekaru 12 zuwa sama ana saka su a cikin hular kwalba mai launi iri ɗaya - launin toka, bisa ga nunin faifai daga gabatarwar CDC ga masu ba da shawara kimiyya a makon da ya gabata. Likitocin ya kamata su karanta lakabin don bambance alluran rigakafin yau da kullun daga sabbin masu haɓakawa.
Biyu vials sun ƙunshi adadin adadin alluran rigakafi - 30 micrograms - amma an samar da maganin gargajiya ne kawai a kan nau'in ƙwayar cuta ta coronavirus, yayin da ingantaccen maganin rigakafin ya ware rabin don nau'in asali kuma sauran don BA.4/BA.5 Omicron subvariant .
Sabunta alamar ƙarar Pfizer don haɗawa da "Bivalent" da "Asali & Omicron BA.4/BA.5" .
Wata hanyar da za ta iya haifar da rudani tare da maganin Moderna shine cewa kwalabe na biyu na maganin gargajiya na farko na yara masu shekaru 6 zuwa 11 da sabon maganin ƙarfafawa ga manya suna da duhu blue.
Duk vials sun ƙunshi kashi ɗaya na maganin rigakafi - 50 mcg. Amma duk matakan farko na sigar yara ana ƙididdige su akan ainihin nau'in coronavirus. Rabin Ƙarfafa Sabuntawar Manya don nau'in asali ne sauran kuma na BA.4/BA.5 sub-variant.
Alamar ƙaramar Omicron da aka sabunta tana cewa "Bivalent" da "Asali da Omicron BA.4/BA.5" .
Masu samar da allurar dole ne su kula don tabbatar da cewa suna ba da maganin da ya dace ga wanda ya dace.
A wani taron manema labarai a ranar Talata, Jami'in ba da amsa COVID-19 na Fadar White House Dr. Ashish Jha ya ce masana kimiyya na FDA suna aiki don tabbatar da masu samar da alluran rigakafin horar da ma'aikata yadda ya kamata ta yadda "mutane za su iya samun rigakafin da ya dace."
“Ba mu ga wata shaida da ke nuna cewa an sami babban kuskure ko kuma cewa mutane suna karbar maganin da bai dace ba. Ina da yakinin cewa tsarin zai ci gaba da aiki yadda ya kamata, amma na san FDA za ta ci gaba da sanya ido kan hakan sosai." Ya ce.
Daraktar CDC Dr. Rochelle Walensky ta ce hukumarta tana aiki tukuru don rarraba hotuna da kuma ilmantar da masu kula da rigakafin "don rage rudani."
Rong-Gong Lin II mai ba da rahoto ne na Metro na San Francisco ƙwararre kan amincin girgizar ƙasa da cutar ta COVID-19 a duk faɗin jihar. Asalin yankin Bay ya sauke karatu daga UC Berkeley kuma ya shiga Los Angeles Times a cikin 2004.
Luc Money ɗan jarida ne na Metro wanda ke ba da labarin karya ga Los Angeles Times. A baya can, shi ɗan jarida ne kuma mataimakin editan birni na Orange County Times Daily Pilot, gidan watsa labarai na jama'a, kuma kafin hakan ya rubuta wa siginar Santa Clarita Valley. Yana da digiri na farko a aikin jarida daga Jami'ar Arizona.


Lokacin aikawa: Janairu-29-2023